Select Publications
Journal articles
2011, 'Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis', Osteoporosis International, 22, pp. 967 - 982, http://dx.doi.org/10.1007/s00198-010-1424-x
,2011, 'Development of a simple prognostic nomogram for individualising 5-year and 10-year absolute risks of fracture: a population-based prospective study among postmenopausal women', Annals of the Rheumatic Diseases, 70, pp. 92 - 97, http://dx.doi.org/10.1136/ard.2010.131813
,2011, 'Four-year Results of a Phase 2 Study of the Cathepsin K Inhibitor Odanacatib in Postmenopausal Women with Low Bone Mineral Density: Effects on Bone Mineral Density and Bone Turnover Markers', Journal of Clinical Densitometry, 14, pp. 165 - 165, http://dx.doi.org/10.1016/j.jocd.2011.02.042
,2011, 'Genetic profiling and individualized prognosis of fracture', Journal of Bone and Mineral Research, 26, pp. 414 - 419, http://dx.doi.org/10.1002/jbmr.219
,2011, 'Genome-wide association study using extreme truncate selection identifies novel genes affecting bone mineral density and fracture risk', PLOS Genetics, 7, pp. e1001372, http://dx.doi.org/10.1371/journal.pgen.1001372
,2011, 'Independent external validation of nomograms for predicting risk of low-trauma fracture and hip fracture', Canadian Medical Association Journal (CMAJ), 183, pp. E107 - E114, http://dx.doi.org/10.1503/cmaj.100458
,2011, 'Odanacatib in the treatment of postmenopausal women with low bone mineral density: three-year continued therapy and resolution of effect', Journal of Bone and Mineral Research, 26, pp. 242 - 251, http://dx.doi.org/10.1002/jbmr.212
,2011, 'Osteoporosis medication and reduced mortality risk in elderly women and men', Journal of Clinical Endocrinology and Metabolism, 96, pp. 1006 - 1014, http://dx.doi.org/10.1210/jc.2010-2730
,2011, 'Risk factors for in-hospital post-hip fracture mortality', Bone, 49, pp. 553 - 558, http://dx.doi.org/10.1016/j.bone.2011.06.002
,2011, 'Vitamin D status and parathyroid hormone in a urban population in Vietnam', Osteoporosis International, 22, pp. 241 - 248, http://dx.doi.org/10.1007/s00198-010-1207-4
,2010, 'Individualized Prognosis of Fracture in Men', , pp. 361 - 373, http://dx.doi.org/10.1016/B978-0-12-374602-3.00029-8
,2010, 'VDR gene polymorphisms on risk of osteoporotic hip fracture in an adult population spanish', Ars Pharmaceutica, 51, pp. 193 - 201
,2010, 'Managing the patient with osteoporosis', Medicine Today, 11
,2010, 'Vitamin D deficiency in adults', Australian Prescriber, 33, pp. 103 - 106, http://dx.doi.org/10.18773/austprescr.2010.053
,2010, 'Clinical fractures cluster in time after initial fracture', Maturitas, 67, pp. 339 - 342, http://dx.doi.org/10.1016/j.maturitas.2010.09.002
,2010, 'Odanacatib in the treatment of postmenopausal women with low bone mineral density: 3-year continued therapy and resolution of effect', Bone, 47, pp. S68 - S68, http://dx.doi.org/10.1016/j.bone.2010.04.132
,2010, 'Odanacatib in the Treatment of Postmenopausal Women with Low Bone Mineral Density: 3-Year Continued Therapy and Resolution of Effect', Journal of Clinical Densitometry, 13, pp. 133 - 133, http://dx.doi.org/10.1016/j.jocd.2010.01.087
,2010, 'Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density', Journal of Bone and Mineral Research, 25, pp. 937 - 947, http://dx.doi.org/10.1359/jbmr.091035
,2010, 'Pharmacogenetics of osteoporosis-related bone fractures: moving towards the harmonization and validation of polymorphism diagnostic tools', Pharmacogenomics, 11, pp. 1287 - 1303, http://dx.doi.org/10.2217/pgs.10.116
,2009, 'Genetics of Osteoporosis', , pp. 213 - 219, http://dx.doi.org/10.1002/9780470623992.ch42
,2009, 'Investigation of incidental hypercalcaemia', BMJ (Online), 339, pp. 1308 - 1310, http://dx.doi.org/10.1136/bmj.b4613
,2009, 'Global vitamin D status and determinants of hypovitaminosis D (Osteoporosis International DOI:10.1007/s00198-009-0954-6)', Osteoporosis International, 20, pp. 1821, http://dx.doi.org/10.1007/s00198-009-1030-y
,2009, 'Adequacy of Vitamin D Replacement in Severe Deficiency Is Dependent on Body Mass Index', American Journal of Medicine, 122, pp. 1056 - 1060
,2009, 'Common variants in the region around Osterix are associated with bone mineral density and growth in childhood', Human Molecular Genetics, 18, pp. 1510 - 1517
,2009, 'Critical interplay between neuropeptide Y and sex steroid pathways in bone and adipose tissue homeostasis', Journal of Bone and Mineral Research, 24, pp. 294 - 304
,2009, 'Enhancement of Absolute Fracture Risk Prognosis with Genetic Marker: The Collagen I Alpha 1 Gene', Calcified Tissue International, 85, pp. 379 - 388, http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19789904
,2009, 'Global vitamin D status and determinants of hypovitaminosis D', Osteoporosis International, 20, pp. 1807 - 1820
,2009, 'Investigation of incidental hypercalcaemia', British Medical Journal, 339, pp. 4613
,2009, 'Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women', JAMA - Journal of the American Medical Association, 301, pp. 513 - 521
,2009, 'Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight', PLoS Clinical Trials, 4, pp. e8415 - e
,2009, 'New sequence variants associated with bone mineral density', Nature Genetics, 41, pp. 15 - 17
,2009, 'Population rates of bone densitometry use in Australia, 2001-2005, by sex and rural versus urban location', Medical Journal of Australia, 190, pp. 126 - 128
,2009, 'Timing of repeat BMD measurements: Development of an absolute risk-based prognostic model', Journal of Bone and Mineral Research, 24, pp. 1800 - 1807
,2009, 'Two-Year Results of Odanacatib (MK-822) Treatment in Postmenopausal Women with Low Bone Mineral Density', Journal of Clinical Densitometry, 12, pp. 395 - 395, http://dx.doi.org/10.1016/j.jocd.2009.03.024
,2009, 'Vitamin D deficiency in critically ill patients', New England Journal of Medicine, 360, pp. 1912 - 1914
,2009, 'Vitamin D deficiency in the intensive care unit: an invisible accomplice to morbidity and mortality?', Intensive Care Medicine, 35, pp. 2028 - 2032
,2008, 'Association between LRP5 polymorphism and bone mineral density: a Bayesian meta-analysis - art. no. 55', BMC Medical Genetics, 9, pp. 55 - 55
,2008, 'Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks', Osteoporosis International, 19, pp. 1431 - 1444
,2008, 'Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study', Journal of Rheumatology, 35, pp. 488 - 497
,2008, 'Endogenous sex hormones and incident fracture risk in older men - The Dubbo Osteoporosis Epidemiology Study', Archives of Internal Medicine, 168, pp. 47 - 54
,2008, 'Endorphins regulate bone homeostasis by actions through dynorphin', Bone, 42, pp. S43 - S44, http://dx.doi.org/10.1016/j.bone.2007.12.070
,2008, 'Genetic analyses in a sample of individuals with high or low BMD shows association with multiple Wnt pathway genes', Journal of Bone and Mineral Research, 23, pp. 499 - 506, http://dx.doi.org/10.1359/JBMR.071113
,2008, 'Incidence and risk factors for low trauma fractures in men with prostate cancer', Bone, 43, pp. 556 - 560
,2008, 'Multiple genetic loci for bone mineral density and fractures', New England Journal of Medicine, 358, pp. 2355 - 2365
,2008, 'Osteoporosis prevention and treatment in elderly men - a cost-effective strategy', NATURE CLINICAL PRACTICE ENDOCRINOLOGY and METABOLISM, 4, pp. 198 - 199, http://dx.doi.org/10.1038/ncpendmet0753
,2008, 'Pharmacogenetics of osteoporosis and the prospect of individulized prognosis and individulized therapy', Current Opinion in Endocrinology and Diabetes, 15, pp. 481 - 488
,2008, 'Treatment of Paget`s disease of bone: A survey of clinical practice in Australia', Bone, 42, pp. 1219 - 1225, http://dx.doi.org/10.1016/j.bone.2008.01.024
,2007, 'Fourteen years negotiating the polishing and publishing of science', Journal of Bone and Mineral Research, 22, pp. 1829 - 1830, http://dx.doi.org/10.1359/jbmr.0712jae
,2007, 'Challenges in science and academic-industry interactions', Journal of Bone and Mineral Research, 22, pp. 1654 - 1655, http://dx.doi.org/10.1359/jbmr.07090a
,2007, 'Maintaining the trust of physicians and the public in the medical literature: Report of a Task Force on Scientific Publishing of Clinical Trials', Journal of Bone and Mineral Research, 22, pp. 1661 - 1667, http://dx.doi.org/10.1359/jbmr.07090c
,